Quintiles (NYSE: Q) can add two more awards to its trophy cabinet at its Durham headquarters.
The world’s largest lifer science company receives the top “Contract Research Organization” honor for the second consecutive year at the annual Scrip Awards.
Its Infosario Safety product wins the top honor for best technological development in clinical trials.
The prestigious awards were handed out Thursday in London.
The ninth annual awards were presented by Scrip Intelligence, a source for news and strategic analysis for the pharmaceutical industry.
The complete list of winners follows:
- Best Company in an Emerging Market - Dr Reddy’s Laboratories – India
- Best Technological Development in Clinical Trials - Quintiles’s Infosario Safety
- Best Partnership Alliance - AstraZeneca with Bristol-Myers Squibb and Amylin in diabetes
- Financing Deal of the Year - Mesoblast’s equity financing of Aus$170m
- Best Advance in an Emerging Market - Novartis’s Jian Kang Kuai Che Healthcare Project in China
- Clinical Advance of the Year – Regeneron Pharmaceuticals and Sanofi’s Phase IIa study dupilumab in in asthma
- Licensing Deal of the Year – AstraZeneca and Horizon Discovery for the development and commercialization of the HD-001 kinase target program for multiple cancer types
- Executive of the Year - Roch Doliveux, chairman and chief executive officer of UCB
- Biotech Company of the Year - Genmab
- Best Contract Research Organization - Quintiles
- Management Team of the Year - Regeneron Pharmaceuticals’ CEO Leonard S Schleifer and CSO George D Yancopoulos
- Best New Drug – Novartis’ Bexsero (meningococcal group B vaccine)
- Pharma Company of the Year – Astellas
- Lifetime Achievement Award - Dr. Désiré Collen
